ACLS-Algorithms.com. Amiodarone and ACLS. ACLS-Algorithms.com. Accessed October 15, 2020. https://acls-algorithms.com/acls-drugs/amiodarone-and-acls/
Colunga Biancatelli RM, Congedo V, Calvosa L, Ciacciarelli M, Polidoro A, Iuliano L. Adverse reactions of amiodarone. J Geriatr Cardiol. 2019;16(7):552-566. doi:10.11909/j.issn.1671-5411.2019.07.004
Hamilton D Sr, Nandkeolyar S, Lan H, et al. Amiodarone: A comprehensive guide for clinicians. Am J Cardiovasc Drugs. 2020;20(6):549-558. doi:10.1007/s40256-020-00401-5
Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects: A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994;121(7):529-535. doi:10.7326/0003-4819-121-7-199410010-00009
MedScape. Amiodarone (Rx). MedScape. Accessed October 15, 2020. https://reference.medscape.com/drug/pacerone-cordarone-amiodarone-342296
Rubinstein E, Camm J. Cardiotoxicity of fluoroquinolones. J Antimicrob Chemother. 2002;49(4):593-596. doi:10.1093/jac/49.4.593
U.S. Food and Drug Administration. Cordarone (amiodarone HCl) tablets. U.S. Food and Drug Administration. Accessed October 15, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018972s042lbl.pdf
Wolkove N, Baltzan M. Amiodarone pulmonary toxicity. Can Respir J. 2009;16(2):43-48. doi:10.1155/2009/282540



